This McKesson Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Baird analyst Eric Coldwell upgraded the rating for McKesson Corporation MCK from Neutral to Outperform and raised the price target from $531 to $688. McKesson shares closed at $549.31 on Wednesday. See how other analysts view this stock.
Raymond James analyst Ric Prentiss upgraded United States Cellular Corporation USM from Market Perform to Outperform and announced a price target of $86. United States Cellular shares closed at $65.15 on Wednesday. See how other analysts view this stock.
Cantor Fitzgerald analyst Kristen Kluska upgraded the rating for Sarepta Therapeutics, Inc. SRPT from Neutral to Overweight and boosted the price target from $152 to $167. Sarepta Therapeutics shares closed at $127.97 on Wednesday. See how other analysts view this stock.
JP Morgan analyst Alexei Gogolev upgraded Clearwater Analytics Holdings, Inc. CWAN from Neutral to Overweight and raised the price target from $23 to $33. Clearwater Analytics shares closed at $28.58 on Wednesday. See how other analysts view this stock.
Wells Fargo analyst Steven Cahall upgraded the rating for Sinclair, Inc. SBGI from Underweight to Equal-Weight and increased the price target from $13 to $19. Sinclair shares closed at $17.41 on Wednesday. See how other analysts view this stock.

Considering buying MCK stock? Here’s what analysts think:

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.